NAD+ is a critical coenzyme for cellular energy production, DNA repair, and sirtuin activity, with levels known ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis biotech company has ...

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks Cofactor Genomics, a ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

Lindsey Ellefson is Lifehacker’s Features Editor. She currently covers study and productivity hacks, as well as household and digital decluttering, and oversees the freelancers on the sex and ...

Lindsey Ellefson is Lifehacker’s Features Editor. She currently covers study and productivity hacks, as well as household and digital decluttering, and oversees the freelancers on the sex and ...

We are testing system that has a protein + constant cofactor + ligands (congeneric series) As the cofactor is constant we are exporting along with the protein. When ...

Ready to unlock your full math potential? 🎓Follow for clear, fun, and easy-to-follow lessons that will boost your skills, build your confidence, and help you master math like a genius—one step at a ...

Cofactor Genomics announced the latest validation results for OncoPrism ®, Cofactor's breakthrough RNA-based diagnostic approach at the RNA Society's 30th Annual Meeting. The talk, presented by Dr.

SAN DIEGO--(BUSINESS WIRE)--Cofactor Genomics announced the latest validation results for OncoPrism ®, Cofactor’s breakthrough RNA-based diagnostic approach at the RNA Society’s 30th Annual Meeting.